Sonnet BioTherapeutics HoldingsSONN 
$1.001.01%24h
1.01%24h
Global rank35411
Market cap$1.04M
Change 7d-
YTD Performance-42.53%
SP500 benchmarkUnderperform
P/E-0.06
P/S7.02
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings (SONN) Net Assets
SONN Net Assets in 2023: $-225.98K
As of 27 Oct 2024, Sonnet BioTherapeutics Holdings net assets is $-225.98K, an decrease of -91.10% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Sonnet BioTherapeutics Holdings overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Sonnet BioTherapeutics Holdings Net Assets History from 2019 to 2024
-
Value:-
SONN Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $-225.98K | -91.10% |
| 2022 | $-2.54M | -111.40% |
| 2021 | $22.26M | 637.10% |
| 2020 | $3.02M | -206.13% |
| 2019 | $-2.85M | - |
View the Top Net Assets Companies
